Raymond Harris
Targeting diabetic kidney disease
Oct. 16, 2018—Raymond Harris, Ming-Zhi Zhang and colleagues suggest pathways activated by the epidermal growth factor receptor may be promising targets for treating diabetic kidney disease.
Mass spectrometry team earns grant to map body at the cellular level
Sep. 28, 2018—Biochemistry professor Richard Caprioli, director of the Mass Spectrometry Research Center, and Jeff Spraggins, research assistant professor of biochemistry, and their team will build a platform to molecularly characterize cells.
YAP after acute kidney injury
Aug. 17, 2018—ianchun Chen, Raymond Harris and colleagues have identified a potential new target for treating acute kidney injury.
Ikizler to succeed Harris as Nephrology and Hypertension director
Jun. 28, 2018—T. Alp Ikizler, MD, an internationally known expert on the nutritional and metabolic aspects of kidney disease, will succeed Raymond Harris, MD, as director of the Department of Medicine’s Division of Nephrology and Hypertension in the Vanderbilt University School of Medicine effective July 1.
New tools to combat kidney fibrosis
Oct. 13, 2017—Vanderbilt investigators have developed a new mouse model of kidney fibrosis, which provides a platform for identifying new targets and treatment strategies.
Major grant to enhance kidney disease research
Sep. 28, 2017—Vanderbilt’s Division of Nephrology and Hypertension has received a five-year, $5 million federal grant to provide core research services in the fight against kidney disease.
Vanderbilt, Bayer collaborate to develop new therapies against kidney diseases
Sep. 11, 2017—Vanderbilt University Medical Center (VUMC) and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases, with the goal of accelerating the translation of innovative approaches from the laboratory to pre-clinical development.
Immune system a must for kidney repair
Nov. 12, 2015—A signaling protein that is essential for recovery from acute kidney injury works by increasing the population of tissue-repairing immune cells.
Harris to lead American Society of Nephrology
Nov. 12, 2015—Ray Harris, M.D., has been elected president of the American Society of Nephrology during the society’s annual meeting, ASN Kidney Week 2015, in San Diego.
Study sheds light on side effects of COX-2 drugs
Oct. 22, 2015—A team of Vanderbilt University Medical Center scientists are closer to understanding why COX-2 inhibitors — drugs that relieve arthritis pain and inflammation without the gastrointestinal side effects of other painkillers — cause heart problems in some patients. Now
Study: Why one kidney can work as well as two
Jun. 11, 2015—Vanderbilt University researchers have come closer to solving a mystery that has puzzled scientists for more than a century: after the loss of one kidney, what causes the growth of the remaining kidney to take up the slack?
NIH grant spurs diabetic nephropathy research
Oct. 30, 2014—Diabetic nephropathy, or kidney disease caused by diabetes, is a major source of morbidity and mortality. In the United States, more than 30 percent of patients receiving either dialytic therapy or renal transplantation have end stage renal disease as a result of diabetic nephropathy.